Cardinal Health Recalls Certain LEADER Brand Eye Drops

RTTNews | 419 days ago
Cardinal Health Recalls Certain LEADER Brand Eye Drops

(RTTNews) - Cardinal Health, Inc. is recalling certain Leader branded eye drops supplied by Velocity Pharma, LLC citing potential risk of eye infections, according to the US. Food and Drug Administration.

The recall was initiated after the FDA informed the Dublin, Ohio-based company that investigators found insanitary conditions in the manufacturing facility and positive bacterial test results from environmental sampling of critical drug production areas in the facility.

To date, Cardinal Health have received reports of three adverse events related to these recalled products, and the details were shared with its supplier, Velocity Pharma.

The recall involves all lots of over- the-counter or OTC ophthalmic sterile drops supplied by Velocity Pharma to the consumer level.

The products include Eye Irritation Relief; Dry Eye Relief; Lubricant Eye Drops; and Lubricant Eye Drops under LEADER brand that are packaged in various sizes.

The products were distributed across the United States to wholesalers and retailers starting December 12, 2021.

These are used for temporary relief of burning and irritation due to dryness of the eye as well as for use as a protectant against further irritation or to relieve dryness of the eye. Further, the products are also used to relieve redness of the eye due to minor eye irritations. The products are intended to be sterile.

According to the agency, there is a potential risk of eye infections for the patients who use these impacted products that could result in partial vision loss or blindness.

Cardinal Health urged wholesalers, distributors and retailers to cease the distribution of these affected products, and consumers to stop using them. They may return the impacted products to the place of purchase.

In recent incidents, Phoenix, Arizona-based Pharmedica USA LLC in Match recalled Purely Soothing, 15 percent MSM eye drops to the consumer level due to non-sterility.

In mid- September, the FDA had warned eight companies including CVS Health and Walgreens Boots Alliance, Inc. against manufacturing or marketing unapproved ophthalmic drug products in violation of federal law.

For More Such Health News, visit rttnews.com

read more
Cardinal Health Lifts FY24 View Above Market After Profit In Q4, Plans Buyback; Stock Up

Cardinal Health Lifts FY24 View Above Market After Profit In Q4, Plans Buyback; Stock Up

Shares of Cardinal Health, Inc. were gaining more than 7 percent in the pre-market activity on the NYSE after the healthcare company on Wednesday raised its fiscal 2024 adjusted earnings forecast above the market after reporting a profit in its fourth quarter, compared to prior year's loss. The improved results reflected strong revenues from both segments.
RTTNews | 133 days ago
Cardinal Health To Merge Outcomes Business To Transaction Data Systems

Cardinal Health To Merge Outcomes Business To Transaction Data Systems

Cardinal Health, Inc. (CAH) announced Monday it has signed a definitive agreement to merge its Outcomes business to Transaction Data Systems (TDS), a portfolio company of BlackRock Long Term Private Capital and GTCR, in exchange for a minority stake in the combined entity.
RTTNews | 569 days ago
Cardinal Health Appoints Aaron Alt As New CFO

Cardinal Health Appoints Aaron Alt As New CFO

Cardinal Health (CAH) and its board of directors announced Monday that Aaron Alt will become the company's new chief financial officer (CFO). Alt will succeed interim CFO, Trish English and will report to CEO Jason Hollar, as a member of the company's Executive Committee effective February 10.
RTTNews | 737 days ago
Cardinal Health Reaffirms FY23 Outlook - Update

Cardinal Health Reaffirms FY23 Outlook - Update

While reporting financial results for the first quarter on Friday, healthcare services company Cardinal Health, Inc. (CAH) reaffirmed its adjusted earnings guidance for the full-year 2023 in the range of $5.05 to $5.40 per share.
RTTNews | 782 days ago
Cardinal Health Promotes CFO Jason Hollar To Succeed Mike Kaufmann As CEO

Cardinal Health Promotes CFO Jason Hollar To Succeed Mike Kaufmann As CEO

Healthcare services company Cardinal Health (CAH) announced Thursday that its Board of Directors has elected Jason Hollar as the company's next Chief Executive Officer, effective September 1, 2022. Hollar will also join the Board of Directors effective August 11, 2022. Hollar will succeed current Chief Executive Officer Mike Kaufmann.
RTTNews | 867 days ago
Yen Slides Against Majors

Yen Slides Against Majors

The Japanese yen weakened against other major currencies in the Asian session on Wednesday.
RTTNews | 13h 40min ago
Yen Falls Against Majors

Yen Falls Against Majors

The Japanese yen weakened against other major currencies in the Asian session on Wednesday.
RTTNews | 14h 15min ago